semaglutide & tirzepatide Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity Before You Inject: Why You

Eva Winning Lehmann, Signe Srensen Torekov, Glucagon-like peptide-1 receptor agonists: the key to healthy weight loss maintenance?, Cardiovascular Research, Volume 117, Issue 10, 1 September 2021, Pages e120e122, Jensen SBK, Blond MB, Sandsdal RM, Olsen LM, Juhl CR, Lundgren JR, Janus C, Stallknecht BM, Holst JJ, Madsbad S, Torekov SS

It looks like progress

Chronic Disease Management: It addresses obesity at a hormonal and metabolic level, supporting patients in managing a chronic, complex disease

Tip #3: Seek Support and Communication A collaborative approach ensures that healthcare providers and patients work to address challenges, fostering a successful treatment experience